Cargando…

Why is there persistent disease despite biologic therapy? Importance of early intervention

This short article hypothesizes that the major reason for persistent disease despite biologic therapy is the inappropriately late timing of therapy with biologic agents. There is clear evidence to support this hypothesis. This short review will indicate that patients treated at an earlier phase of d...

Descripción completa

Detalles Bibliográficos
Autor principal: Emery, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075238/
https://www.ncbi.nlm.nih.gov/pubmed/25167379
http://dx.doi.org/10.1186/ar4594
_version_ 1782323310522007552
author Emery, Paul
author_facet Emery, Paul
author_sort Emery, Paul
collection PubMed
description This short article hypothesizes that the major reason for persistent disease despite biologic therapy is the inappropriately late timing of therapy with biologic agents. There is clear evidence to support this hypothesis. This short review will indicate that patients treated at an earlier phase of disease can achieve a clinical remission rate of 70% and a response rate of above 95%.
format Online
Article
Text
id pubmed-4075238
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40752382014-12-26 Why is there persistent disease despite biologic therapy? Importance of early intervention Emery, Paul Arthritis Res Ther Commentary This short article hypothesizes that the major reason for persistent disease despite biologic therapy is the inappropriately late timing of therapy with biologic agents. There is clear evidence to support this hypothesis. This short review will indicate that patients treated at an earlier phase of disease can achieve a clinical remission rate of 70% and a response rate of above 95%. BioMed Central 2014 2014-06-26 /pmc/articles/PMC4075238/ /pubmed/25167379 http://dx.doi.org/10.1186/ar4594 Text en Copyright © 2014 Emery; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 The licensee has exclusive rights to distribute this article, in any medium, for 6 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Emery, Paul
Why is there persistent disease despite biologic therapy? Importance of early intervention
title Why is there persistent disease despite biologic therapy? Importance of early intervention
title_full Why is there persistent disease despite biologic therapy? Importance of early intervention
title_fullStr Why is there persistent disease despite biologic therapy? Importance of early intervention
title_full_unstemmed Why is there persistent disease despite biologic therapy? Importance of early intervention
title_short Why is there persistent disease despite biologic therapy? Importance of early intervention
title_sort why is there persistent disease despite biologic therapy? importance of early intervention
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075238/
https://www.ncbi.nlm.nih.gov/pubmed/25167379
http://dx.doi.org/10.1186/ar4594
work_keys_str_mv AT emerypaul whyistherepersistentdiseasedespitebiologictherapyimportanceofearlyintervention